Efficacy and safety of pyrotinib‐containing regimen in the patients with HER2‐positive metastatic breast cancer: A multicenter real‐world study

por Yin, Sha, Chi, Yajing, Du, Yangyang, Wang, Jingfen, Shan, Changping, Yi, Weiwei, Shang, Mao, Man, Xiaochu, Tan, Qiaorui, Li, Huihui
Publicado 2022

Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized...

por Xu, Binghe, Zhang, Qingyuan, Hu, Xichun, Li, Qing, Sun, Tao, Li, Wei, Ouyang, Quchang, Wang, Jingfen, Tong, Zhongsheng, Yan, Min, Li, Huiping, Zeng, Xiaohua, Shan, Changping, Wang, Xian, Yan, Xi, Zhang, Jian, Zhang, Yue, Wang, Jiani, Zhang, Liang, Lin, Ying, Feng, Jifeng, Chen, Qianjun, Huang, Jian, Zhang, Lu, Yang, Lisong, Tian, Ying, Shang, Hongyan
Publicado 2023